已收盤 02-06 16:00:00 美东时间
+0.780
+2.53%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Match Group业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **Q4 2025财务表现:** - 总营收:8.78亿美元,同比增长2%,汇率中性基础上持平 - 调整后EBITDA:3.7亿美元,同比增长14%,调整后EBITDA利润率为42%(剔除特殊项目后为41%) - 自由现金流:2025全年超过10亿美元 **2025全年财务表现:** - 总营收:35亿美元,同比持平(汇率中性基础上也持平) - 调整后EBITDA:12亿美元,同比下降1%,调整后EBITDA利润率为35%(剔除法律和解、重组成本及洛杉矶办公楼出售收
02-04 12:13
Match Group shares are trading higher after the company reported better-than-ex...
02-04 05:35
Match Group将于2026年2月3日发布季度财报,分析师预期EPS为0.94美元,营收为8.7249亿美元。公司过去四个季度业绩均不及预期,投资者期待本次财报能超预期并给出乐观指引。
02-04 05:22
Match Group (NASDAQ:MTCH) just disclosed its Q4 earnings on Tuesday, February 3...
02-04 05:14
Match Group (NASDAQ:MTCH) sees FY2026 sales of $3.410 billion-$3.535 billion vs $3.593 billion analyst estimate.
02-04 05:14
Match Group (NASDAQ:MTCH) sees Q1 sales of $850.000 million-$860.000 million vs $853.263 million analyst estimate.
02-04 05:13
Match Group (NASDAQ:MTCH) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.71 by 16.9 percent. This is a 40.68 percent increase over earnings of $0.59 per share from the same
02-04 05:13
Match Group (NASDAQ:MTCH) is preparing to release its quarterly earnings on Tue...
02-03 03:02